UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Date of report (Date of earliest event reported): April 5, 2013

 

Bacterin International Holdings, Inc.

	(Exact Name of Registrant as Specified in Its Charter)
	Delaware
	(State or Other Jurisdiction of Incorporation)
	001-34951	20-5313323
	(Commission File Number)	(IRS Employer Identification No.)
	600 Cruiser Lane Belgrade, Montana	59714
	(Address of Principal Executive Offices)	(Zip Code)
(406) 388-0480
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   £ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   £ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   £ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   £ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

ITEM 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

 

Guy Cook resigned from his roles of Chief Executive Officer, President and Chairman of the Board effective April 5, 2013.

 

The Board unanimously voted to have Kent Swanson, an existing independent director, serve as Acting Chairman of the Board.

 

Our current Chief Financial Officer, John Gandolfo, and our Chief Operating Officer, Darrel Holmes, will jointly serve as interim Co-Chief Executive Officers until the Board appoints a new Chief Executive Officer.

 

Information for John Gandolfo and Darrel Holmes required by Items 401(b), (d), (e) and Item 404(a) of Regulation S-K is contained in our Annual Report on Form 10-K filed with the SEC on March 27, 2013 and incorporated by reference herein.

 

 

 

SIGNATURE

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: April 5, 2013

BACTERIN INTERNATIONAL HOLDINGS, INC.

 

 

 

By:  /s/ John Gandolfo                                                                                      

Name: John Gandolfo

Title: Interim Co-Chief Executive Officer and Chief Financial Officer